| |
|
|
|
Cleveland BioLabs Inc.  
|
|
1.34 0 (0%) |
01-17 10:31 |
|
Open: |
1.33 |
Pre close: |
1.34 |
Target:
|
1.85
|
|
High: |
1.34 |
Low: |
1.33 |
Resistance:
|
1.59
1.95
|
|
Volume: |
1,191 |
Market Cap: |
15M |
Support:
|
1.00
0.83
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.35
|
MACD |
MACD(12,26):
|
-0.08  |
|
MA(20): |
1.31  |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
1.72 |
Stochastic Oscillator |
%K(14,3):
|
45.05 |
|
MA(250): |
2.40 |
%D(3): |
48.50 |
|
Average Volume(K) |
3-Month: |
856
|
52-Week |
High:
|
3.96 |
|
10-Days: |
815 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
45.73 |
Change(%): |
-64.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-367.6 |
Shares Out. (M) |
11.30 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-52.5 |
Shares Float (M) |
7.64 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-4.6 |
% Held by Institutions |
6.50 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
146.140 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.72 |
P/S |
93931248.00 |
|
Operating Margin |
-303.78 |
Levered Free Cash Flow
(M) |
-3.59 |
P/CF |
-3.18 |
|
|
|
|
|
|
